DE3277307D1 - Recombinant plasmid containing human interferon-beta gene - Google Patents

Recombinant plasmid containing human interferon-beta gene

Info

Publication number
DE3277307D1
DE3277307D1 DE8282111895T DE3277307T DE3277307D1 DE 3277307 D1 DE3277307 D1 DE 3277307D1 DE 8282111895 T DE8282111895 T DE 8282111895T DE 3277307 T DE3277307 T DE 3277307T DE 3277307 D1 DE3277307 D1 DE 3277307D1
Authority
DE
Germany
Prior art keywords
recombinant plasmid
plasmid containing
containing human
human interferon
beta gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282111895T
Other languages
English (en)
Inventor
Seiga Itoh
Tatsunari Nishi
Tamio Mizukami
Tadashi Matsumoto
Tetsuo Oka
Tadatsugu Taniguchi
Haruo Sugano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japanese Foundation for Cancer Research
KH Neochem Co Ltd
Original Assignee
Japanese Foundation for Cancer Research
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japanese Foundation for Cancer Research, Kyowa Hakko Kogyo Co Ltd filed Critical Japanese Foundation for Cancer Research
Application granted granted Critical
Publication of DE3277307D1 publication Critical patent/DE3277307D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/142—Interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
DE8282111895T 1981-12-25 1982-12-22 Recombinant plasmid containing human interferon-beta gene Expired DE3277307D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56213193A JPS58110600A (ja) 1981-12-25 1981-12-25 ヒトβ型インタ−フエロン遺伝子を含む組みかえ体プラスミド

Publications (1)

Publication Number Publication Date
DE3277307D1 true DE3277307D1 (en) 1987-10-22

Family

ID=16635072

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282111895T Expired DE3277307D1 (en) 1981-12-25 1982-12-22 Recombinant plasmid containing human interferon-beta gene

Country Status (5)

Country Link
US (1) US4686191A (de)
EP (1) EP0083069B1 (de)
JP (1) JPS58110600A (de)
CA (1) CA1211059A (de)
DE (1) DE3277307D1 (de)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58141796A (ja) * 1982-02-18 1983-08-23 Kyowa Hakko Kogyo Co Ltd ペプチドの製造法
AU575301B2 (en) * 1982-10-08 1988-07-28 Juridical Foundation, Japanese Foundation For Cancer Research Novel vector
JPH0740925B2 (ja) * 1983-03-14 1995-05-10 協和醗酵工業株式会社 新規ヒトインタ−フエロン−γポリペプチド
JPS59203495A (ja) * 1983-04-28 1984-11-17 Kyowa Hakko Kogyo Co Ltd 外来遺伝子の新規な発現方法
US4746608A (en) * 1983-08-22 1988-05-24 Kyowa Hakko Kogyo Co., Ltd. Process for producing peptides
JPS60188077A (ja) * 1984-03-09 1985-09-25 Teruhiko Beppu 仔牛プロキモシンｃＤΝＡの全配列を有する新規な発現プラスミド
EP0165613B1 (de) * 1984-06-22 1992-01-15 Hitachi, Ltd. Verfahren zum Kontrollieren der Züchtung von Rekombinanten
FR2579224B1 (fr) * 1985-03-25 1987-05-22 Genetica Procede de preparation microbiologique de la serum-albumine humaine
DK156072C (da) * 1985-04-03 1989-11-06 Nordisk Gentofte Syntetisk dna-sekvens indeholdende et ribosombindingssted
NO176799C (no) 1986-12-23 1995-05-31 Kyowa Hakko Kogyo Kk DNA som koder for et polypeptid, rekombinant plasmid som koder for og kan uttrykke et polypeptid og fremgangsmåte for fremstilling av dette polypeptid
DE4128319A1 (de) * 1991-08-27 1993-03-04 Bioferon Biochem Substanz Neues rekombinantes human-ifn-beta, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
US6806076B1 (en) 1998-04-14 2004-10-19 Kyowa Hakko Kogyo Co., Ltd. Process for producing isoprenoid compounds by microorganisms and a method for screening compounds with antibiotic or weeding activity
EP2077275A3 (de) 1998-06-02 2009-08-12 Nihon University IgA-Nephropathie-bezogene DNA
US6531122B1 (en) * 1999-08-27 2003-03-11 Maxygen Aps Interferon-β variants and conjugates
US7144574B2 (en) * 1999-08-27 2006-12-05 Maxygen Aps Interferon β variants and conjugates
US7431921B2 (en) 2000-04-14 2008-10-07 Maxygen Aps Interferon beta-like molecules
WO2001098493A1 (fr) 2000-06-15 2001-12-27 Kyowa Hakko Kogyo Co., Ltd Proteine de liaison de facteur de croissance insulinoide
FR2810674A1 (fr) * 2000-06-22 2001-12-28 Pf Medicament Construction modifiee en amont du codon d'initiation pour la surexpression de proteines recombinantes
US20020169290A1 (en) * 2000-11-02 2002-11-14 Claus Bornaes New multimeric interferon beta polypeptides
JP3765574B2 (ja) * 2001-02-22 2006-04-12 三菱化学株式会社 逆向き反復配列を含む組み換え遺伝子及びその利用
MXPA03007619A (es) 2001-02-27 2003-12-04 Maxygen Aps Nuevas moleculas similares a interferon beta.
US20040117868A1 (en) * 2002-01-29 2004-06-17 Jun Imamura Protein participating in restoration from cytoplasmic male sterility to fertility and gene encoding the same
WO2002088179A1 (fr) 2001-04-25 2002-11-07 Mitsubishi Chemical Corporation Proteine participant a la restauration de fertilite de la sterilite male cytoplasmique et gene codant ladite proteine
US6995236B2 (en) 2001-05-08 2006-02-07 Riken Sphingomyelin detecting probe
EP1437412A4 (de) * 2001-09-20 2005-02-02 Plantech Res Inst An der synthese von fettsäure mit einer trans-11-, cis-13-konjugierten doppelbindung beteiligte gene und verwendung davon
JP2003144141A (ja) * 2001-11-14 2003-05-20 Gencom Co ＲＮＡｉ効果が増強したＥＳ細胞
CN100513576C (zh) 2002-05-08 2009-07-15 协和发酵生化株式会社 胞苷5’-二磷酸胆碱的制备方法
JP4171256B2 (ja) * 2002-07-18 2008-10-22 三菱化学株式会社 パピローマウイルスベクターを用いたＲＮＡｉ表現型を有する非ヒト哺乳動物の作製方法
CA2497338A1 (en) 2002-08-30 2004-03-18 Japan Science And Technology Corporation Method of targeted gene disruption, genome of hyperthermostable bacterium and genome chip using the same
JP2004180641A (ja) * 2002-12-06 2004-07-02 Gencom Co ＲＮＡｉ表現型を有する非ヒト哺乳動物の作製方法
AU2003296151A1 (en) 2002-12-26 2004-07-22 Kyowa Hakko Kogyo Co., Ltd. Process for producing dipeptide
ATE486936T1 (de) * 2003-03-05 2010-11-15 Chemo Sero Therapeut Res Inst Verfahren zur herstellung eines heterologen proteins in e. coli
AU2005211385B2 (en) 2004-02-02 2008-12-11 Ambrx, Inc. Modified human growth hormone polypeptides and their uses
US20080076729A1 (en) * 2005-05-19 2008-03-27 Schering Aktiengesellachaft Interferon-beta gene therapy using an improved, regulated expression system
EP1891224A1 (de) * 2005-05-19 2008-02-27 Bayer Schering Pharma Aktiengesellschaft Interferon-beta-gentherapie unter verwendung eines verbesserten, regulierten expressionssystems
US20070179113A1 (en) * 2005-05-19 2007-08-02 Schering Aktiengesellachaft GM-CSF gene therapy for Crohn's disease using an improved regulated expression system
AR053285A1 (es) * 2005-05-19 2007-04-25 Schering Ag Tratamiento de enfemedades usando un sistema mejorado de expresion regulada
WO2007037245A1 (ja) 2005-09-29 2007-04-05 Shionogi & Co., Ltd. 血管新生抑制作用を有するポリペプチド
US8058037B2 (en) 2005-11-29 2011-11-15 Kyowa Hakko Bio Co., Ltd. Protein and DNA encoding the protein
JP5095416B2 (ja) 2005-12-06 2012-12-12 協和発酵キリン株式会社 抗ｐｅｒｐ遺伝子組換え抗体
EP1978094B1 (de) 2005-12-27 2012-03-14 Kyowa Hakko Bio Co., Ltd. Verfahren zur herstellung von l-glutamin
CA2654572A1 (en) 2006-06-06 2007-12-13 Kyowa Hakko Kirin Co., Ltd. Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
EP2067857B1 (de) 2006-09-25 2012-04-11 Kyowa Hakko Bio Co., Ltd Verfahren zur dipeptidherstellung
US20100075343A1 (en) 2007-01-25 2010-03-25 Motoo Yamasaki Novel peptides
WO2008114733A1 (ja) 2007-03-16 2008-09-25 Kyowa Hakko Kirin Co., Ltd. 抗Claudin-4抗体
JP5256192B2 (ja) 2007-03-29 2013-08-07 国立大学法人 岡山大学 バソヒビン含有治療剤
CN101715490B (zh) 2007-04-06 2014-02-05 协和发酵生化株式会社 谷胱甘肽及γ-谷氨酰半胱氨酸的制造方法
EP2143786B1 (de) 2007-04-06 2014-12-10 Kyowa Hakko Bio Co., Ltd. Verfahren zur dipeptidherstellung
CA2685596A1 (en) * 2007-05-02 2008-11-13 Ambrx, Inc. Modified interferon beta polypeptides and their uses
SG192433A1 (en) 2007-09-27 2013-08-30 Shionogi & Co Method for producing hydroxylated adamantane using cytochrome p450
JP5532401B2 (ja) 2007-12-05 2014-06-25 協和発酵キリン株式会社 ヘパリン結合上皮細胞増殖因子様増殖因子に結合するモノクローナル抗体
US9023999B2 (en) 2008-06-30 2015-05-05 Kyowa Hakko Kirin Co., Ltd Anti-CD27 antibody
CN103145835B (zh) 2008-07-17 2014-10-29 协和发酵麒麟株式会社 抗-系统asc氨基酸转运蛋白2 (asct2)抗体
CN102232111B (zh) 2008-10-09 2014-12-03 协和梅迪克斯株式会社 果糖基肽氧化酶
DK2374883T3 (en) 2008-12-26 2016-09-26 Kyowa Hakko Kirin Co Ltd Anti-cd4 antibody
WO2010090330A1 (ja) 2009-02-09 2010-08-12 協和発酵バイオ株式会社 Ｌ－アミノ酸の製造法
EP2423228B1 (de) 2009-04-20 2015-12-16 Kyowa Hakko Kirin Co., Ltd. Antikörper mit igg2 und darin eingeführten mutierten aminosäuren
KR101846590B1 (ko) 2010-06-11 2018-04-09 교와 핫꼬 기린 가부시키가이샤 항 ｔｉｍ-3 항체
JP5058332B2 (ja) 2010-07-14 2012-10-24 住友ゴム工業株式会社 イソプレンオリゴマー、ポリイソプレン、及びこれらの製造方法、ゴム組成物、並びに空気入りタイヤ
CN103781800A (zh) 2011-06-20 2014-05-07 协和发酵麒麟株式会社 抗erbB3抗体
CA2874117C (en) 2012-07-02 2021-10-12 Kyowa Hakko Kirin Co., Ltd. Pharmaceutical agent comprising anti-bmp9 antibody as active ingredient for treatment of anemia such as renal anemia and cancer anemia
ES2691794T3 (es) 2012-12-07 2018-11-28 Kyowa Hakko Kirin Co., Ltd. Anticuerpo anti-FOLR1
US9944970B2 (en) 2013-07-09 2018-04-17 Kyowa Medex Co., Ltd. Glycated hexapeptide oxidase and use thereof
WO2017150695A1 (ja) 2016-03-04 2017-09-08 国立大学法人新潟大学 変異型テトラプレニル－β－クルクメン環化酵素及びアンブレインの製造方法
EP3492591A4 (de) 2016-07-26 2020-04-01 Shizuoka Prefecture Anti-b7-h4-antikörper
MY190347A (en) 2016-08-10 2022-04-15 Spiber Inc Production method for insoluble recombinant protein aggregate
EP3521299A4 (de) 2016-10-03 2020-06-24 Spiber Inc. Verfahren zur aufreinigung rekombinanter proteine
WO2018190398A1 (ja) 2017-04-13 2018-10-18 協和発酵バイオ株式会社 テアニンの製造方法
CN110914430B (zh) 2017-07-13 2023-11-21 协和麒麟株式会社 抗bril抗体以及使用了该抗体的bril融合蛋白质的稳定化方法
JP7197865B2 (ja) 2017-07-18 2022-12-28 協和キリン株式会社 抗ヒトｃｃｒ１モノクローナル抗体
WO2019022163A1 (ja) 2017-07-26 2019-01-31 Ｓｐｉｂｅｒ株式会社 改変フィブロイン
CN111094571B (zh) 2017-09-01 2023-10-27 国立大学法人新潟大学 龙涎香醇的有效制备方法
CN111344307A (zh) 2017-11-08 2020-06-26 协和麒麟株式会社 与CD40和EpCAM结合的双特异性抗体
CA3085563A1 (en) 2017-12-12 2019-06-20 Kyowa Kirin Co., Ltd. Anti-bmp10 antibody, and therapeutic agent for hypertension and hypertensive diseases comprising said antibody as an active ingredient
CN112424357A (zh) 2018-06-26 2021-02-26 协和麒麟株式会社 与硫酸软骨素蛋白聚糖5结合的抗体
CA3105000A1 (en) 2018-06-26 2020-01-02 Kyowa Kirin Co., Ltd. Antibody binding to cell adhesion molecule 3
JPWO2020032258A1 (ja) 2018-08-10 2021-08-12 協和発酵バイオ株式会社 多価不飽和脂肪酸を生産する微生物及び多価不飽和脂肪酸の製造法
BR112021002300A2 (pt) 2018-08-10 2021-05-04 Kyowa Hakko Bio Co., Ltd microrganismo que produz ácido eicosapentaenoico e método para a produção de ácido eicosapentaenoico
KR20210108961A (ko) 2018-12-28 2021-09-03 쿄와 기린 가부시키가이샤 TfR에 결합하는 이중 특이적 항체
WO2020145363A1 (ja) 2019-01-09 2020-07-16 Ｓｐｉｂｅｒ株式会社 改変フィブロイン
BR112021014805A2 (pt) 2019-01-31 2022-01-04 Spiber Inc Métodos de produção para uma proteína recombinante e para aumentar o volume de produção
KR20220008820A (ko) 2019-05-15 2022-01-21 쿄와 기린 가부시키가이샤 Cd40과 fap에 결합하는 이중 특이적 항체
EP3971293A4 (de) 2019-05-15 2023-02-08 Kyowa Kirin Co., Ltd. Zur bindung an cd40 und gpc3 fähiger bispezifischer antikörper
JPWO2021125245A1 (de) 2019-12-16 2021-06-24
TW202140561A (zh) 2020-02-14 2021-11-01 日商協和麒麟股份有限公司 與cd3結合之雙特異性抗體
KR20220155328A (ko) 2020-03-16 2022-11-22 스파이버 가부시키가이샤 합성 고분자 및 그의 제조 방법, 성형 재료, 그리고, 성형체
US20240141402A1 (en) 2020-06-25 2024-05-02 Kyowa Hakko Bio Co., Ltd. Method for producing dipeptide
JPWO2022168991A1 (de) 2021-02-08 2022-08-11
CN117836326A (zh) 2021-08-26 2024-04-05 协和麒麟株式会社 与cd116和cd131结合的双特异性抗体
WO2023038128A1 (ja) 2021-09-10 2023-03-16 協和発酵バイオ株式会社 Ｃｄｐ－コリンの製造に用いる組換え微生物及び該組換え微生物を用いるｃｄｐ－コリンの製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52036B1 (en) * 1979-05-24 1987-05-27 Univ California Non-passageable viruses
GB2052516B (en) * 1979-06-01 1983-06-29 Searle & Co Plasmid vectors production and use thereof
ZA811368B (en) * 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
EP0041313B1 (de) * 1980-04-03 1990-09-12 Biogen, Inc. DNS-Sequenzen, rekombinante DNS-Moleküle und Verfahren zur Herstellung von dem menschlichen Fibroblast-Interferon
FR2490675B1 (fr) * 1980-09-25 1985-11-15 Genentech Inc Production microbienne d'interferon de fibroplaste humain

Also Published As

Publication number Publication date
CA1211059A (en) 1986-09-09
EP0083069B1 (de) 1987-09-16
EP0083069A3 (en) 1984-03-28
JPH0134599B2 (de) 1989-07-20
JPS58110600A (ja) 1983-07-01
EP0083069A2 (de) 1983-07-06
US4686191A (en) 1987-08-11

Similar Documents

Publication Publication Date Title
DE3277307D1 (en) Recombinant plasmid containing human interferon-beta gene
DE3273787D1 (en) Human interferon-beta gene
DE3279371D1 (en) Plasmid
GB8520632D0 (en) Plasmid
GB8508809D0 (en) Interleukin therapy
IL67517A0 (en) Interferon formulations
GB8416007D0 (en) Recombinant plasmid
GB2159717B (en) Medical electrode
GB8516591D0 (en) Urogastone gene
GB8516618D0 (en) Polyether polyols
ZA829344B (en) Interferon formulations
IL69851A0 (en) Novel dna and recombinant plasmid containing the same
PT83207A (en) Baking furnace for electrodes
GB8425778D0 (en) Plasmid
IL64783A (en) Recombinant plasmid and use thereof
GB8529452D0 (en) Recombinant plasmid
GB8723340D0 (en) Recombinant genes
GB8723341D0 (en) Recombinant genes
IE860656L (en) Expression plasmid
IL95502A0 (en) Plasmid
GB8710413D0 (en) Recombinant genes & products
GB8710411D0 (en) Recombinant genes & products
GB8710410D0 (en) Recombinant genes & products
GB8710407D0 (en) Recombinant genes & products
GB8710408D0 (en) Recombinant genes & products

Legal Events

Date Code Title Description
8364 No opposition during term of opposition